BECTON, DICKINSON AND COMPANY Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
BECTON, DICKINSON AND COMPANY (BDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $20.00 million for the 12-month period ending 2017-09-30, per its 10-K filed 2017-11-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2017-11-22
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $20.00M, a 60.78% decline from fiscal 2016.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $51.00M, a 1.92% decline from fiscal 2015.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2015 was $52.00M, a 147.62% increase from fiscal 2014.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $21.00M, a 67.69% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|
| 2017-09-30 | $20.00M 10-K · filed 2017-11-22 | |
| 2016-09-30 | $51.00M 10-K · filed 2017-11-22 | |
| 2015-09-30 | $52.00M 10-K · filed 2017-11-22 | |
| 2014-09-30 | $21.00M 10-K · filed 2016-11-23 | |
| 2013-09-30 | $65.00M 10-K · filed 2015-11-25 | |
| 2012-09-30 | $58.00M 8-K · filed 2015-03-13 | $57.91M 10-K · filed 2012-11-21 |
| 2011-09-30 | $138.00M 10-K · filed 2013-11-27 | $137.72M 10-K · filed 2011-11-23 |
| 2010-09-30 | $89.94M 10-K · filed 2012-11-21 | |
| 2009-09-30 | $53.63M 10-K · filed 2011-11-23 | |
| 2008-09-30 | $191.63M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |